Suggestions
Eric Leire
CEO Genflow Biosciences
Eric Leire is a highly experienced executive in the biotechnology and pharmaceutical industries. He currently serves as a Non-Executive Director at InhaTarget Therapeutics, a Belgian company developing targeted inhalation formulations for severe respiratory diseases, with a focus on lung cancer.3
Professional Background
Dr. Leire is the founder and CEO of Genflow Biosciences, a company focused on longevity and gene therapy.12 He brings over two decades of experience in cell and gene therapy to his roles.2 His career highlights include:
- Chief Executive Officer positions at several biotech companies, including APT Therapeutics, Paringenix, Enochian Biosciences (NASDAQ: ENOB), and DanDrit Biotechnologies (OTC.QB: DDRT)1
- Experience in the pharmaceutical industry with companies like Pfizer, Schering Plough, and Pharmacia1
- Research Associate at the Harvard AIDS Institute1
- Partner at Biofund Venture Capital1
Board Positions
Dr. Leire serves on the boards of several biotechnology companies:
- Pherecydes (ALPH.PA)
- Immunethep
- BSIM Therapeutics
- OSE Immunotherapeutics SA
- PHAXIAM Therapeutics SA13
Education
Eric Leire holds the following degrees:
- MD from Grenoble University
- MBA from HEC, Paris
- MBA from Kellogg School of Management, Northwestern University1
Expertise
Dr. Leire is known for his expertise in:
- Biotechnology
- Cell and gene therapy
- Drug development
- Pharmaceutical industry operations
- Venture capital in healthcare
He is also an inventor of several patents, demonstrating his innovative contributions to the field.1
Dr. Eric Leire's LinkedIn profile can be found under the username eric-leire-9841ab5, where he is listed as the CEO of GenFlow Biosciences.4
